ADACEL

Brand name authorized in: Brazil Canada Cyprus Hong Kong Lithuania Poland Singapore United States

Active ingredients

The drug ADACEL contains a combination of these active pharmaceutical ingredients (APIs):

1 Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Tetanus toxoid
2 Diphtheria toxoid
UNII IRH51QN26H - CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Diphtheria toxoid
3 Pertussis, purified antigen
UNII F4TN0IPY37 - BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)
Read about Pertussis, purified antigen
4 Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
Read about Pertussis filamentous hemagglutinin
5 Pertussis, purified antigen
UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
Read about Pertussis, purified antigen
6 Pertussis, purified antigen
UNII 1O0600285A - BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN
Read about Pertussis, purified antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
J07AJ52
Pertussis, purified antigen, combinations with toxoids
J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines
Discover more medicines within J07AJ52

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 576720060074617
CA
Health Products and Food Branch
Identifier(s): 02240255
HK
Department of Health Drug Office
Identifier(s): 57327
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1038464, 1053396, 1073901, 1073902, 1080472, 1080473, 1080474, 1080475
SG
Health Sciences Authority
Identifier(s): 14232P
US
FDA, National Drug Code
Identifier(s): 49281-400